Health
Roche gantenerumab improves biomarkers in inherited form of Alzheimer’s disease – PMLiVE
However, anti-amyloid antibody did not show evidence of cognitive benefit for patients
A new study, published in Nature Medicine, has showed that Roche’s investigational candidate gantenerumab led to improvements in a number of biomarkers in patients with an inherited form of Alzheimer’s disease.
In the DIAN-TU-001 trial, researchers from…
Continue Reading
-
General21 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News17 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General10 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
General20 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba